Better Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
BTTX on OTC
Location
548 Market St. #49404, San Francisco, CA

There are no Buy or Sell transactions made by insiders since 9/14/2023

Better Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Perry Executive Chairman, Director, 10%+ Owner $3.7M Feb 9, 2024
Georgianna Maule-Ffinch 2015 Trust 10%+ Owner $618K Apr 10, 2023
Kevin J. Appelbaum Chief Executive Officer, Director, 10%+ Owner $410K Mar 31, 2022
Geoffrey M. Parker Director $184K Dec 18, 2023
Andrew Armanino Director $127K Dec 18, 2023
Frank Karbe Chief Executive Officer, Director $89.5K Dec 18, 2023
Mark A. Berman Chief Medical Officer $76.1K Dec 18, 2023
Kristin Wynholds Chief Product Officer $38.3K Dec 18, 2023
Richard H. Carmona Director $26.7K Dec 18, 2023
Mark Heinen Chief Financial Officer $24.1K Mar 1, 2023
Elder Granger Director $6.73K Dec 18, 2023
Justin Zamirowski Chief Commercial Officer $6.27K May 27, 2022
Leslie Miller Principal Accounting Officer $3.05K Dec 18, 2023
Risa Lavizzo Mourey Director $2.34K Dec 18, 2023
Suying Liu Director Jun 9, 2022

Recent Insider Transactions by Companies or Individuals for Better Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.